Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Cross-Verification of In-Process Data – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Cross-Verification of In-Process Data – V 2.0

Standard Operating Procedure for Cross-Verification of In-Process Data


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/080/2025
Supersedes SOP/SIM/080/2022
Page No. Page 1 of 12
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define a standardized procedure for cross-verification of in-process control (IPC) data to ensure completeness, correctness, consistency, and integrity of recorded observations in sterile injectable manufacturing.

2. Scope

This SOP is applicable to all personnel involved in production and quality assurance activities in sterile injectable areas where IPC

data is generated and recorded for compliance and product quality verification.

3. Responsibilities

  • Production Officer: Responsible for ensuring accurate recording of IPC parameters in real-time.
  • QA Officer: Responsible for cross-verifying recorded IPC data against equipment logs, observations, and batch records.
  • Production Supervisor: Reviews and signs off IPC records before submission to QA.
See also  Sterile Injectable Manufacturing: SOP for Handling Hazardous Materials during Dispensing - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for implementation and oversight of the cross-verification process for IPC records.

5. Procedure

5.1 Identification of IPC Data

  1. Identify IPC parameters such as volume, pH, temperature, vacuum, sealing integrity, etc., required for each product.
  2. Refer to the approved BMR (Batch Manufacturing Record) and IPC checklist for each product batch.

5.2 Collection and Recording of IPC Data

  1. Record IPC results immediately after each check in the IPC data sheet (Annexure-1).
  2. Ensure entries are legible, signed, and dated by the responsible person.

5.3 Cross-Verification Steps by QA

  1. Obtain completed IPC records from Production.
  2. Compare recorded values with:
    • Equipment printouts/logs
    • Automated data logger output (if applicable)
    • Visual verification during line clearance or sampling
  3. Mark any discrepancies in red ink and raise a deviation report (if required).
  4. Verify calibration status of instruments used during IPC.
See also  Sterile Injectable Manufacturing: SOP for Packing Prefilled Syringes in Secondary Packaging - V 2.0

5.4 Data Review and Documentation

  1. Review data for completeness, accuracy, consistency, and traceability.
  2. Ensure changes/corrections are counter-signed with justification.
  3. Summarize cross-verification outcome in IPC Verification Summary Log (Annexure-2).

5.5 Handling Discrepancies

  1. QA shall initiate deviation report for critical or unexplained mismatches.
  2. Perform root cause analysis and corrective actions as per deviation SOP.

5.6 Archival of Verified Data

  1. After QA sign-off, all IPC records and verification logs shall be archived with the respective BMR.
  2. Retention period shall follow the regulatory retention SOP (minimum 5 years).

6. Abbreviations

  • IPC: In-Process Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • SOP: Standard Operating Procedure

7. Documents

  1. IPC Data Sheet – Annexure-1
  2. IPC Verification Summary Log – Annexure-2
  3. Deviation Report – Annexure-3 (if applicable)

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – Current Good Manufacturing Practice
  • WHO TRS 986 – Annex 2: GMP for Sterile Pharmaceutical Products
See also  Formulation Development: SOP for Risk Management in Product Development Lifecycle - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: IPC Data Sheet

Date Batch No. Parameter Observed Value Recorded By
18/06/2025 INJ-5412 Filling Volume 1.00 mL Ajay Nair

Annexure-2: IPC Verification Summary Log

Batch No. Data Verified Discrepancies Found QA Reviewer Date
INJ-5412 Yes No Sunita Reddy 19/06/2025

Annexure-3: Deviation Report

Deviation ID Description Root Cause Corrective Action Status
DEV-323 pH mismatch in IPC vs. data logger Sensor drift Recalibrate pH meter Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
18/06/2025 2.0 Updated with Annexures and real-time verification procedure GMP Alignment QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Setting Up Stability Chambers for Gels – V 2.0
Next Post: Biosimilars: SOP for Media Filtration Before Use – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version